Minneapolis
89°F
eEdition
News & Politics
Sports
Food & Culture
Business
Outdoors
Opinion
Things To Do
Obituaries
More of What Matters to Minnesota
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Minnesota State Top Stocks
Markets
Minnesota Stocks
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Enochian Biosciences Inc
(NQ:
ENOB
)
N/A
UNCHANGED
Last Price
Updated: 4:00 PM EDT, Aug 4, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Enochian Biosciences Inc
< Previous
1
2
3
Next >
Kirby McInerney LLP Reminds Investors That a Class Action Lawsuit Has Been Filed on Behalf of Enochian Biosciences, Inc. (ENOB) Investors and Encourages Investors to Contact the Firm Before September 26, 2022
September 02, 2022
From
Kirby McInerney LLP
Via
Business Wire
ROSEN, A TOP RANKED LAW FIRM, Encourages Enochian BioSciences, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - ENOB
August 27, 2022
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Lawsuit
Exposures
Financial
Legal
ROSEN, A LEADING NATIONAL FIRM, Encourages Enochian BioSciences, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - ENOB
August 24, 2022
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Lawsuit
Exposures
Financial
Legal
Enochian Biosciences, Inc. (NASDAQ:ENOB) Investor Notice: Lawsuit Alleges Securities Laws Violations
August 18, 2022
San Diego, CA -- (SBWIRE) -- 08/18/2022 -- An investor, who purchased shares of Enochian Biosciences, Inc. (NASDAQ:ENOB), filed a lawsuit against Enochian Biosciences, Inc over alleged Securities Laws...
Via
SBWire
Enochian Biosciences Inc. Shareholder Notice: Robbins LLP is Investigating Enochian Biosciences Inc. (ENOB) on Behalf of Shareholders
August 15, 2022
From
Robbins LLP
Via
Business Wire
ROSEN, TRUSTED NATIONAL TRIAL COUNSEL, Encourages Enochian BioSciences, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - ENOB
August 12, 2022
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Lawsuit
Exposures
Financial
Legal
GLOBALLY RECOGNIZED ROSEN LAW FIRM Encourages Enochian BioSciences, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - ENOB
August 10, 2022
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Lawsuit
Exposures
Financial
Legal
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Enochian BioSciences, Inc. Investors With Losses to Secure Counsel Before Important Deadline in Securities Class Action – ENOB
August 08, 2022
From
Rosen Law Firm
Via
Business Wire
INVESTOR DEADLINE: Investors in Enochian Biosciences Inc. with Substantial Losses Have Opportunity to Lead Class Action Lawsuit – ENOB
August 06, 2022
From
Robbins Geller Rudman & Dowd LLP
Via
Business Wire
Kirby McInerney LLP Reminds Investors That a Class Action Lawsuit Has Been Filed on Behalf of Enochian Biosciences, Inc. (ENOB) Investors and Encourages Investors to Contact the Firm Before September 26, 2022
August 05, 2022
From
Kirby McInerney LLP
Via
Business Wire
Deadline Reminder: Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Enochian Biosciences, Inc. (ENOB)
August 04, 2022
From
Law Offices of Howard G. Smith
Via
Business Wire
Bronstein, Gewirtz & Grossman, LLC Notifies Enochian Biosciences Inc. (ENOB) Investors of Class Action and Encourages Investors to Contact the Firm
August 03, 2022
From
Bronstein, Gewirtz & Grossman, LLC
Via
Business Wire
The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of Enochian Biosciences, Inc. (ENOB) Investors
August 02, 2022
From
Law Offices of Frank R. Cruz
Via
Business Wire
INVESTOR NOTICE: Enochian Biosciences Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - ENOB
August 02, 2022
From
Robbins Geller Rudman & Dowd LLP
Via
Business Wire
Enochian Biosciences Inc. Shareholder Update: Robbins LLP Reminds Investors of Class Action Against Enochian Biosciences Inc. (ENOB)
August 01, 2022
From
Robbins LLP
Via
Business Wire
ENOB CLASS ACTION NOTICE: The Law Offices of Frank R. Cruz Files Securities Fraud Lawsuit Against Enochian Biosciences, Inc.
August 01, 2022
From
The Law Offices of Frank R. Cruz
Via
Business Wire
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Enochian Biosciences, Inc. (ENOB)
August 01, 2022
From
Glancy Prongay & Murray LLP
Via
Business Wire
SHAREHOLDER ACTION REMINDER: The Schall Law Firm Encourages Investors in Enochian Biosciences, Inc. with Losses of $100,000 to Contact the Firm
August 01, 2022
From
The Schall Law Firm
Via
Business Wire
ENOB SHAREHOLDER ALERT: ROSEN, SKILLED INVESTOR COUNSEL, Encourages Enochian BioSciences, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - ENOB
July 31, 2022
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Lawsuit
Exposures
Financial
Legal
SHAREHOLDER ACTON ALERT: The Schall Law Firm Encourages Investors in Enochian Biosciences, Inc. with Losses of $100,000 to Contact the Firm
July 29, 2022
From
The Schall Law Firm
Via
Business Wire
INVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Enochian Biosciences, Inc. (ENOB) Investors
July 29, 2022
From
Law Offices of Howard G. Smith
Via
Business Wire
ENOB CLASS ACTION NOTICE: Glancy Prongay & Murray LLP Files Securities Fraud Lawsuit Against Enochian Biosciences, Inc.
July 28, 2022
From
Glancy Prongay & Murray LLP
Via
Business Wire
EQUITY ALERT: Rosen Law Firm Encourages Enochian BioSciences, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – ENOB
July 28, 2022
From
The Rosen Law Firm, P.A.
Via
Business Wire
Shareholder Alert: Robbins LLP Informs Investors of Class Action Against Enochian Biosciences Inc. (ENOB)
July 28, 2022
From
Robbins LLP
Via
Business Wire
ENOCHIAN ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Enochian Biosciences, Inc. and Encourages Investors to Contact the Firm
July 27, 2022
From
Bragar Eagel & Squire, P.C.
Via
Business Wire
INVESTOR ALERT: Enochian Biosciences Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - ENOB
July 27, 2022
From
Robbins Geller Rudman & Dowd LLP
Via
Business Wire
INVESTOR ACTON ALERT: The Schall Law Firm Encourages Investors in Enochian Biosciences, Inc. with Losses of $100,000 to Contact the Firm
July 27, 2022
From
The Schall Law Firm
Via
Business Wire
SHAREHOLDER ACTON NOTICE: The Schall Law Firm Encourages Investors in Enochian Biosciences, Inc. with Losses of $100,000 to Contact the Firm
July 26, 2022
From
The Schall Law Firm
Via
Business Wire
Kirby McInerney LLP Announces an Investigation of Shareholder Claims Against Enochian Biosciences, Inc. (ENOB)
July 07, 2022
From
Kirby McInerney LLP
Via
Business Wire
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Continues Investigation of Enochian Biosciences, Inc. (ENOB) on Behalf of Investors
July 06, 2022
From
Glancy Prongay & Murray LLP
Via
Business Wire
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.